<SEC-DOCUMENT>0001213900-25-058995.txt : 20250627
<SEC-HEADER>0001213900-25-058995.hdr.sgml : 20250627
<ACCEPTANCE-DATETIME>20250627160151
ACCESSION NUMBER:		0001213900-25-058995
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20250627
DATE AS OF CHANGE:		20250627
EFFECTIVENESS DATE:		20250627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABVC BIOPHARMA, INC.
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288377
		FILM NUMBER:		251086174

	BUSINESS ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-668-0881

	MAIL ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	American BriVision (Holding) Corp
		DATE OF NAME CHANGE:	20160111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0246580-s8_abvc.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on June 27, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-[&#9679;]</B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>ABVC BIOPHARMA, INC.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; font-size: 10pt; text-align: center; width: 49%"><FONT STYLE="font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; font-size: 10pt; text-align: center; width: 49%"><FONT STYLE="font-size: 10pt"><B>26-0014658</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top">(State or other jurisdiction of<BR> incorporation or organization)</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">(I.R.S. Employer<BR> Identification No.)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>44370 Old Warm Springs Blvd.,</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Fremont, CA 94538</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>(510) 668-0881</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Second Amended and Restated 2016 Equity Incentive
Plan</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Dr. Uttam Patil</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Chief Executive Officer</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>44370 Old Warm Springs Blvd.,</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Fremont, CA 94538</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>(510)-668-0881- telephone</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Louis Taubman, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hunter Taubman Fischer &amp; Li LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>950 Third Avenue, 19<SUP>th&nbsp;</SUP>Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: (917) 512-0827</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 35%"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="text-align: justify; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 35%; text-align: left"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 15%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Registration Statement on Form S-8 is being
filed by ABVC BIOPHARMA, INC. (the &ldquo;Registrant&rdquo;) to register an additional 2,515,989 shares of common stock, par value $0.001
per share (the &ldquo;Common Stock&rdquo;), authorized for issuance under the Second Amended and Restated 2016 Equity Incentive Plan (the
&ldquo;Second Amended and Restated Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 1. PLAN INFORMATION. *</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE
PLAN ANNUAL INFORMATION. * </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>*</B> The document(s) containing the information
specified in this Part I will be sent or given to participants in the 2016 Plan in accordance with Rule 428(b)(1) under the Securities
Act. Such documents need not be filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These document(s)
and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II hereof, taken together, constitute
a prospectus that meets the requirements of Section 10(a) of the Securities Act.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following documents filed by the Company with
the Securities and Exchange Commission (the &ldquo;SEC&rdquo; or &ldquo;Commission&rdquo;) pursuant to the Securities Act and the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), are incorporated herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Annual Report on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025032118/ea0232540-10k_abvcbio.htm">Form 10-K</A></FONT> <FONT STYLE="font-size: 10pt">for the year ending December 31, 2024, filed with the SEC on April 15, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Quarterly Report on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025037676/ea0239701-10q_abvcbio.htm">Form 10-Q</A></FONT> <FONT STYLE="font-size: 10pt">for the quarter ended March 31, 2025, filed with the SEC on April 30, 2025;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify">The Company&rsquo;s Current Report
on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025001211/ea0226487-8k_abvcbio.htm">Form 8-K</A>, filed with the SEC on January 6, 2025;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&#9679;</TD>
    <TD>The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025021713/ea023348301-8k_abvcbio.htm">Form 8-K</A>,
    filed with the SEC on March 7, 2025;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&#9679;</TD>
    <TD>The
Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025032135/ea0238372-8k_abvcbio.htm">Form
8-K</A>, filed with the SEC on April 15, 2025;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&#9679;</TD>
    <TD>The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025032468/ea0238544-8ka1_abvcbio.htm">Form 8-K/A</A>,
    filed with the SEC on April 16, 2025;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&#9679;</TD>
    <TD>The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025037654/ea0239740-8k_abvcbio.htm">Form 8-K</A>,
    filed with the SEC on April 30, 2025;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025038060/ea0240063-8k_abvcbio.htm">Form 8-K</A></FONT><FONT STYLE="font-size: 10pt">, filed with the SEC on May 1, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025039184/ea024046901-8ka_abvcbio.htm">Form 8-K/A</A>, filed with the SEC on May 2, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025040194/ea0240961-8k_abvcbio.htm">Form 8-K/A</A>, filed with the SEC
    on May 6, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025042982/ea0242092-8ka1_abvcbio.htm">Form 8-K/A</A>, filed with the SEC
    on May 14, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025049491/ea0243649-8ka_abvcbio.htm">Form 8-K/A</A>, filed with the SEC
    on May 30, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company&rsquo;s Current Report on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025051144/ea024460401-8k_abvcbio.htm">Form 8-K</A></FONT><FONT STYLE="font-size: 10pt">, filed with the SEC on June 4, 2025;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The description of the Company&rsquo;s common stock and securities contained on </FONT><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390025032118/ea0232540-10k_abvcbio.htm">Form 10-K</A></FONT> <FONT STYLE="font-size: 10pt">filed with the SEC on April 15, 2025, under Section 12(b) of the Exchange Act, including any amendments or reports filed for the purpose of updating such description; and</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All other reports and documents filed by the Company pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement, except as so modified or superseded.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 4. DESCRIPTION OF SECURITIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s authorized capital stock consists
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100,000,000 shares of Common Stock, $0.001 par value per share; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">20,000,000 shares of preferred stock, $0.001 par value per share.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock may be issued for such consideration
as may be fixed from time to time by our board of directors. Our board of directors may issue such shares of our Common Stock in one or
more series, with such voting powers, shall be stated in the resolution or resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C<B>ommon Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date hereof, there are 16,773,261 shares of
our Common Stock issued and outstanding. Holders of Common Stock are entitled to cast one vote for each share on all matters submitted
to a vote of stockholders, including the election of directors. The holders of Common Stock are entitled to receive ratably such dividends,
if any, as may be declared by the Board out of funds legally available therefore. Such holders do not have any preemptive or other rights
to subscribe for additional shares. All holders of Common Stock are entitled to share ratably in any assets for distribution to stockholders
upon the liquidation, dissolution or winding up of the Company, subject to prior distribution rights of preferred stock then outstanding.
There are no conversions, redemptions or sinking fund provisions applicable to the Common Stock. All outstanding shares of Common Stock
are fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date hereof, there is no preferred stock
outstanding. Pursuant to the articles of incorporation of the Company, the Board of Directors is expressly granted the authority to issue
preferred stock up to 20,000,000 shares and prescribe its designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description of preferred stock and
the description of the terms of any particular series of preferred stock of the Company are not complete. The Company&rsquo;s Board of
Directors has the authority, without further action by the stockholders, to issue shares of preferred stock in one or more series and
to fix the rights, preferences, privileges and restrictions granted to or imposed upon the preferred stock. Any or all of these rights
may be greater than the rights of the Company&rsquo;s Common Stock. These descriptions are qualified in their entirety by reference to
the Company&rsquo;s Articles of Incorporation, as amended, and the certificate of designation relating to each such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nevada Revised Statutes Section
(&ldquo;NRS&rdquo;) 78.138 Subsection 7 provides that, subject to certain very limited statutory exceptions, a director or officer is
not personally liable to the corporation or its stockholders for any damages as a result of any act or failure to act in his or her capacity
as a director or officer, unless it is proven that the act or failure to act constituted a breach of his or her fiduciary duties as a
director or officer and such breach of those duties involved intentional misconduct, fraud or a knowing violation of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation,
as amended, provide that we will indemnify any person against expenses including without limitation, attorney&rsquo;s fees, judgments,
fines and amounts paid in settlement, actually and reasonably incurred by reason of the fact that he or she is or was a director or officer,
or is or was serving at our request as a director or officer of another corporation, partnership, joint venture, trust or other enterprise,
in call circumstances in which, and to the extent that, such indemnification is permitted and provided for by the laws of the State of
Nevada then in effect (the &ldquo;Indemnification Provision&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nevada law provides a statutory
framework covering indemnification of our directors and officers against liabilities and expenses arising out of legal proceedings brought
against them by reason of their status or service as directors or officers. NRS 78.7502 provides that a corporation may indemnify any
person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right
of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&rsquo;
fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) Is not liable pursuant
to NRS 78.138; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) Acted in good faith
and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indemnification may not be
made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion
of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the
extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that
in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court
deems proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that a director,
officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding
referred to in subsections 1 and 2 of NRS Section 78.7502, or in defense of any claim, issue or matter therein, the corporation shall
indemnify him or her against expenses, including attorneys&rsquo; fees, actually and reasonably incurred by him or her in connection with
the defense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors may
cause the Company to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation, or
is or was serving at the request of the Company as a director or officer of another corporation, or as its representative in a partnership,
joint venture. trust or other enterprise against any liability asserted against such person and incurred in any such capacity or arising
out of such status, whether or not the Company would have the power to indemnify such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors may
from time to time adopt further Bylaws with respect to indemnification and amend the Bylaws to provide at all times the fullest indemnification
permitted by the general corporation law of Nevada, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summaries are
necessarily subject to the complete text of the statute, the Articles, the By-Laws and the agreements referred to above and are qualified
in their entirety by reference thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 8. EXHIBITS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the attached Exhibit Index on the page immediately
following the signature pages hereto, which is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 9. UNDERTAKINGS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) The undersigned Registrant
hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(1) To file, during
any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">(i) To include any prospectus required
by Section 10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">(ii) To reflect in the prospectus
any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.55pt; text-align: justify">(iii) To include any material information
with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information
in this Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify"><I>provided, however,</I> that paragraphs
(a)(1)(i) and (a)(1)(ii) do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section
13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 24.5pt">(2) That, for
the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
<I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 24.5pt">(3) To remove
from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) The undersigned Registrant
hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&rsquo;s annual
report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s
annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h) Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant
to the provisions described in Item 6 above, or otherwise, the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer
or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement on Form S-8 to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Taipei on June 27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><B>ABVC BIOPHARMA, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><I>/s/ Uttam Patil</I></FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Uttam Patil</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><B>ABVC BIOPHARMA, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt"><I>/s/ Uttam Patil</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Uttam Patil</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Interim Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>KNOW ALL MEN BY THESE PRESENTS</B>,
that each person whose signature appears below constitutes and appoints Uttam Patil as his or her true and lawful attorney-in-fact, with
full power of substitution and resubstitution for him and in his or her name, place and stead, in any and all capacities to sign any and
all amendments including post-effective amendments to this registration statement and to file the same, with all exhibits thereto, and
other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact
or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the&nbsp;Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on June 27,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 52%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 11%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Uttam Patil</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Uttam Patil</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Uttam Patil</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Interim Chief Financial Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Uttam Patil</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Eugene Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Eugene Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Yen-Hsin Chou</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yen-Hsin Chou</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Hsin-Hui Miao</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Hsin-Hui Miao</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Tsang-Ming Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Tsang-Ming Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Shuling Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Shuling Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Norimi Sakamoto</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Norimi Sakamoto</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Tsung-Shann Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Tsung-Shann Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Chang-Jen Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Chang-Jen Jiang</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Yoshinobu Odaira</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">June 27, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yoshinobu Odaira</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Che-Wei Hsu</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Che-Wei Hsu </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Yu-Min (Francis) Chung </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">June 27, 2025</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yu-Min (Francis) Chung </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 9%; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024658001ex5-1_abvc.htm">Opinion of Hunter Taubman Fischer &amp; Li LLC</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000462/abvcexhibit4.htm"><FONT STYLE="font-size: 10pt">2016 Equity Incentive Plan (Incorporated by reference to Exhibit 4.1 to Company&rsquo;s Registration Statement on Form S-8, filed with the SEC on February 17, 2016)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1173313/000121390021015729/f10k2020ex10-17_americanbriv.htm"><FONT STYLE="font-size: 10pt">Amended and Restated 2016 Equity Incentive Plan (Incorporated by reference
    to Exhibit 10.17 to Company&rsquo;s Annual Report on Form 10-K, filed with the SEC on March 16, 2021)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">10.3*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024658001ex10-3_abvc.htm">Second Amended and Restated 2016 Equity Incentive Plan</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024658001ex23-1_abvc.htm">Consent of Simon &amp; Edward, LLP</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024658001ex5-1_abvc.htm">Consent of Hunter Taubman Fischer &amp; Li LLC (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">107*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ea024658001ex-fee_abvc.htm">Filing Fee Table</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Filed herewith</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">II-7</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea024658001ex5-1_abvc.htm
<DESCRIPTION>OPINION OF HUNTER TAUBMAN FISCHER & LI LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">June
27, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABVC BioPharma,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">44370 Old
Warm Springs Blvd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fremont,
CA 94538</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 0in"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Re:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration
                                            Statement on Form S-8</U></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                            have acted as counsel to ABVC BioPharma, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
                                            in connection with the preparation of Company&rsquo;s Registration Statement on Form S-8
                                            (&ldquo;<B>Registration Statement</B>&rdquo;) being filed with the Securities and Exchange
                                            Commission under the Securities Act of 1933, as amended. The Registration Statement relates
                                            to the registration of an additional 2,515,989 shares of common stock, par value $0.001 per
                                            share (the &ldquo;<B>Common Stock</B>&rdquo;) under the Second Amended and Restated 2016
                                            Equity Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;); these additional shares are of the
                                            same class as those previously registered under the Company&rsquo;s registration statement
                                            on Form S-8 (File No. 333-209577) filed with the Securities and Exchange Commission on February
                                            17, 2016, as amended. Accordingly, upon the effectiveness of this Registration Statement,
                                            an aggregate of 12,489,365 shares of Common Stock (the &ldquo;<B>Shares</B>&rdquo;) will
                                            be registered for issuance under the Plan. This opinion is being rendered in connection with
                                            the filing of the Registration Statement with the Commission. All capitalized terms used
                                            herein and not otherwise defined shall have the respective meanings given to them in the
                                            Registration Statement.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
the basis for the opinions hereinafter expressed, we have examined: (i) originals, or copies certified or otherwise identified, of (a)
the amended and restated certificate of incorporation (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;) of the Company; (b) the
amended and restated bylaws of the Company, as amended; (c) the corporate action taken by the Company that provides for the issuance
or delivery of the Shares to be issued or delivered under the Plan; (d) the Plan and 2016 Equity Incentive Plan which has previously
been filed as Exhibit 4.1 to the Company&rsquo;s Registration Statement on Form S-8 filed with the Commission on February 17, 2016, as
amended on March 15, 2016 (the &ldquo;<B>Original S8</B>&rdquo;), (e) the Original S8 and (f) such other records, agreements, instruments
and documents as we have deemed necessary or advisable for the purposes of this opinion; and (ii) such statutes, including <FONT STYLE="background-color: white">&nbsp;the
applicable statutory provisions of Chapter 78 of the Nevada Revised Statutes</FONT>, and regulations as we have deemed necessary or advisable
for the purposes of this opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have not independently verified any factual matter relating to this opinion. As to questions of fact material to this opinion, we have
relied upon certificates or comparable documents of public officials and of officers and representatives of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, we have examined and relied on the originals or copies certified or otherwise identified to our satisfaction of all such corporate
records of the Company and such other instruments and other certificates of public officials, officers and representatives of the Company
and such other persons, and we have made such investigations of law, as we have deemed appropriate as a basis for the opinion expressed
below. In such examination, we have assumed, without independent verification, the genuineness of all signatures (whether original or
photostatic), the accuracy and completeness of each document submitted to us, the authenticity of all documents submitted to us as originals,
the conformity to original documents of all documents submitted to us as facsimile, electronic, certified, conformed or photostatic copies
thereof. We have further assumed the legal capacity of natural persons, that persons identified to us as officers of the Company are
actually serving in such capacity, that the representations of officers and employees of the Company are correct as to questions of fact
and that each party to the documents we have examined or relied on (other than the Company) has the power, corporate or other, to enter
into and perform all obligations thereunder and also have assumed the due authorization by all requisite action, corporate or other,
of the execution and delivery by such parties of such documents, and the validity and binding effect thereon on such parties. We have
also assumed that the Company will not in the future issue or otherwise make unavailable so many shares of its Common Stock that there
are insufficiently authorized and unissued shares of Common Stock for issuance of the shares issuable upon exercise of the options being
registered in the Registration Statement. We have not independently verified any of these assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
opinions expressed in this opinion letter are limited to the applicable statutory provisions of Chapter 78 of the Nevada Revised Statutes.
We are not opining on, and we assume no responsibility for, the applicability or effect on any of the matters covered herein of: (a)
any other laws; (b) the laws of any other jurisdiction; or (c) the laws of any country, municipality or other political subdivision or
local government agency or authority. The opinions set forth below are rendered as of the date of this opinion letter. We assume no obligation
to update or supplement such opinions to reflect any change of law or fact that may occur. We assume that the issuance of the Shares
will not cause the Company to issue shares of Common Stock in excess of the number of such shares authorized by the Certificate of Incorporation.
The Company has represented to us and we have also assumed that the Company has reserved from its duly authorized but unissued and otherwise
unreserved stock a sufficient number of shares of Common Stock for issuance under the Plan. We have also assumed that the Company will
at all times reserve and keep available out of the aggregate of its authorized by unissued and otherwise unreserved Common Stock, solely
for the purpose of enabling it to issue the Shares in accordance with the Plan, the number of Shares as are then issuable or deliverable
upon the settlement of awards under the Plan. This opinion is limited to the matters set forth herein, and no other opinion should be
inferred beyond the matters expressly stated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
upon the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that the Shares
to be issued under the Plan have been duly authorized, and, upon the issuance and delivery of the Shares in the manner contemplated by
the Plan, and assuming that the Company completes all actions and proceedings required on its part to be taken prior to the issuance
and delivery of the Shares pursuant to the terms of the Plan, including, without limitation, collection of any required payment for the
Shares, the Shares will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                            hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement
                                            and to the reference to our firm and to our opinion in the Registration Statement. In giving
                                            this consent, we do not admit that we are within the category of persons whose consent is
                                            required under Section 7 of the Securities Act, the rules and regulations of the Commission
                                            promulgated thereunder or Item 509 of Regulation S-K.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Very
    truly yours,</FONT></P></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/ Hunter Taubman Fischer &amp; Li LLC</I></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hunter Taubman Fischer &amp; Li LLC</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">www.htflawyers.com
| info@htflawyers.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">950
Third Avenue, 19th Floor - New York, NY 10022 | Office: (212) 530-2206 | Fax: (212) 202-6380</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>ea024658001ex10-3_abvc.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED ABVC BIOPHARMA,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2016 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SECTION 1. PURPOSE</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purposes of this Second
Amended and Restated 2016 Equity Incentive Plan (the &quot;Plan&quot;) are to encourage selected employees, directors and consultants
of ABVC BIOPHARMA, INC. (together with any successor thereto, the &quot;Company&quot;) and its Affiliates (as defined below) to acquire
a proprietary interest in the growth and performance of the Company, to generate an increased incentive to contribute to the Company's
future success and prosperity, thus enhancing the value of the Company for the benefit of its shareholders, and to enhance the ability
of the Company and its Affiliates to attract and retain exceptionally qualified individuals upon whom, in large measure, the sustained
progress, growth and profitability of the Company depend.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 2. DEFINITIONS</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used in the Plan, the following terms shall
have the meanings set forth below:</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Affiliate&rdquo; shall mean (i) any entity that, directly or through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Board of Directors (the &ldquo;Board&rdquo;) or the Committee.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Award&rdquo; shall mean any Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Award, Dividend Equivalent, or Other Stock-Based Award granted under the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Award Agreement&rdquo; shall mean any written agreement, contract, or other instrument or document evidencing any Award granted under the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(d)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Code&rdquo; shall mean the Internal Revenue Code of 1986, as amended from time to time.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(e)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Consultant&rdquo; shall mean a consultant or adviser who provides bona fide services to the Company or an Affiliate as an independent contractor. Service as a consultant shall be considered employment for all purposes of the Plan, except for purposes of satisfying the requirements of Incentive Stock Options.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(f)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&ldquo;Committee&rdquo; shall mean a committee of not fewer than two members, each of whom is a member of the Board and all of whom are disinterested persons, as contemplated by Rule 16b-3 (&ldquo;Rule 16b-3&rdquo;) promulgated under the Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;) and each of whom is an outside director for purposes of Section 162(m) of the Code, acting in accordance with the provisions of Section 3, designated by the Board to administer the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(g)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Dividend Equivalent&rdquo; shall mean any right granted under Section 6(e) of the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(h)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Employee&rdquo; shall mean any employee of the Company or of any Affiliate.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Fair Market Value&rdquo; shall mean, with respect to any property (including, without limitation, any Shares or other Securities), the fair market value of such property determined by such methods or procedures as shall be established from time to time by the Board or the Committee.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(j)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Incentive Stock Option&rdquo; shall mean an option granted under Section 6(a) of the Plan that is intended to meet the requirements of Section 422 of the Code, or any successor provision thereto.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(k)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Non-Qualified Stock Option&rdquo; shall mean an option granted under Section 6(a) of the Plan that is not intended to be an Incentive Stock Option.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(l)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Option&rdquo; shall mean an Incentive Stock Option or a Non-Qualified Stock Option.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(m)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Other Stock-Based Award&rdquo; shall mean any right granted under Section 6(f) of the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(n)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&ldquo;Participant&rdquo; shall mean any person that renders bona fide services to the Company (including, without limitation, the following: a person employed by the Company or an Affiliate in a key capacity; an officer or director of the Company; a person engaged by the Company as a consultant; or a lawyer, law firm, accountant or accounting firm) who receives an Award under the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(o)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Performance Award&rdquo; shall mean any right granted under Section 6(d) of the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(p)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Person&rdquo; shall mean any individual, corporation, partnership, association, joint-stock company, trust, unincorporated organization, or government or political subdivision thereof.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(q)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">INTENTIONALLY LEFT BLANK</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(r)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Released Securities&rdquo; shall mean shares of Restricted Stock as to which all restrictions imposed by the Board or the Committee have expired, lapsed, or been waived.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(s)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Restricted Stock&rdquo; shall mean any Share granted under Section 6(c) of the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(t)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Restricted Stock Unit&rdquo; shall mean any right granted under Section 6(c) of the Plan that is denominated in Shares.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(u)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Shares&rdquo; shall mean the shares of common stock of the Company, $.001 per share par value, and such other securities or property as may become the subject of Awards, or become subject to Awards, pursuant to an adjustment made under Section 4(b) of the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in; font-size: 10pt">(v)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&rdquo;Stock Appreciation Right&rdquo; shall mean any right granted under Section 6(b) of the Plan.</TD></TR>
  </TABLE>


<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 3. ADMINISTRATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan shall be administered by the Board; provided
however, that the Board may delegate such administration to the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of the Plan, the Board
and/or the Committee shall have authority to (a) determine the type or types of Awards to be granted to each Participant under the Plan;
(b) determine the number of Shares to be covered by (or with respect to which payments, rights, or other matters are to be calculated
in connection with) Awards; (c) determine the terms and conditions of any award; (d) determine the time or times when each Award shall
become exercisable and the duration of the exercise period; (e) determine whether, to what extent, and under what circumstances Awards
may be settled in or exercised for cash, Shares, other securities, other Awards, or other property, or canceled, forfeited, or suspended,
and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended; (f) determine whether, to what
extent, and under what circumstances cash, shares, other securities, other Awards, other property, and other amounts payable with respect
to an Award under the Plan shall be deferred either automatically or at the election of the holder thereof or of the Board or the Committee;
(g) construe and interpret the Plan; (h) promulgate, amend and rescind rules and regulations relating to its administration, and correct
defects, omissions and inconsistencies in the Plan or any Award; (i) consistent with the Plan and with the consent of the Participant,
as appropriate, amend any outstanding Award or amend the exercise date or dates; (j) determine the duration and purpose of leaves of absence
which may be granted to Participants without constituting termination of their employment for the purpose of the Plan; and (k) make all
other determinations necessary or advisable for the Plan&rsquo;s administration. The Board and the Committee&rsquo;s interpretation and
construction of any provisions of the Plan or of any Award shall be conclusive and final. No member of the Board or the Committee shall
be liable for any action or determination made in good faith with respect to the Plan or any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of any Award that is intended to qualify
as performance-based compensation for purposes of Section 162(m) of the Code, once the Award is made, neither the Board nor Committee
shall not have discretion to increase the amount of compensation payable under the Award that would otherwise be due upon attainment of
the performance goal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 4. SHARES AVAILABLE FOR AWARDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">SHARES AVAILABLE. Subject to adjustment as provided in Section 4(b):</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">CALCULATION OF NUMBER OF SHARES AVAILABLE. The number of Shares available for granting Awards under the Plan shall be (A) 2,902,010, plus (B) additional Shares as follows: As of January 1 of each year, commencing with the year 2026 and ending with the year that the additional number of shares equals 15% of the number of shares of common stock issued and outstanding as of the December 31 of the previous year, the aggregate number of Shares available for granting Awards under the Plan shall automatically increase by a number of Shares equal to 5% of the total number of Shares issued and outstanding on the immediately preceding December 31.&nbsp;&nbsp;Further, if, after the effective date of the Plan, any Shares covered by an Award granted under the Plan or to which such an Award or award relates, are forfeited, or if an Award or award otherwise terminates without the delivery of Shares or of other consideration, then the Shares covered by such Award or award, or to which such Award or award relates, or the number of Shares otherwise counted against the aggregate number of Shares available under the Plan with respect to such Award or award, to the extent of any such forfeiture or termination, shall again be, or shall become, available for granting Awards under the Plan. Notwithstanding the foregoing, to the extent that the aggregate Fair Market Value of the Shares (determined at the time of grant) with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company or Affiliates) exceeds one hundred thousand dollars ($100,000, or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Non-Qualified Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(ii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">ACCOUNTING FOR AWARDS. For purposes of this Section 4,</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">(A)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">if an Award (other than a Dividend Equivalent) is denominated in Shares, the number of Shares covered by such Award, or to which such Award relates, shall be counted on the date of grant of such Award against the aggregate number of Shares available for granting Awards under the Plan; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt">(B)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Dividend Equivalents and Awards not denominated in Shares shall not be counted against the aggregate number of Shares available for granting Awards under the Plan.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">SOURCES OF SHARES DELIVERABLE UNDER AWARDS. Any shares delivered pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares or of Treasury Shares.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">ADJUSTMENTS. In the event that the Board or the Committee shall determine that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, purchase, or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other similar corporate transaction or event affects the Shares such that an adjustment is determined by the Board or the Committee to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Board or the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and type of Shares (or other securities or property) which thereafter may be made the subject of Awards, (ii) the number and type of Shares (or other securities or property) subject to outstanding Awards, (iii) the number and type of Shares (or other securities or property) specified as the annual per-participant limitation under Section 6(g)(vi), and (iv) the grant, purchase, or exercise price with respect to any Award, or, if deemed appropriate, make provision for a cash payment to the holder of an outstanding Award; provided, however, in each case, that with respect to Awards of Incentive Stock Options no such adjustment shall be authorized to the extent that such authority would cause the Plan to violate Section 422(b)(1) of the Code or any successor provision thereto; and provided, further, however, that the number of Shares subject to any award denominated in Shares shall always be a whole number.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 5. ELIGIBILITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any Employee, Director or Consultant shall be
eligible to receive Awards under the Plan. The Board shall approve any Awards granted to members of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 6. AWARDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">OPTIONS. The Board and the Committee are hereby authorized to grant Options with the following terms and conditions and with such additional terms and conditions, in either case not inconsistent with the provisions of the Plan, as the Board or the Committee shall determine:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">EXERCISE PRICE. The exercise price per Share of each Option shall be determined by the Board or the Committee; provided, however, that such exercise price per Share under any Incentive Stock Option shall not be less than 100% (110% in the case of a &ldquo;10-percent shareholder as such term is used in Section 422(c)(5) of the Code) of the Fair Market Value of a Share on the date of grant of such Incentive Stock Option.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(ii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">OPTION TERM. The term of each Option shall be fixed by the Board or the Committee, provided that no Incentive Stock Option shall have a term greater than 10 years (5 years in the case of a &ldquo;10-percent shareholder) as such term is used in Section 422(c)(5) of the Code).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">TIME AND METHOD OF EXERCISE. The Board or the Committee shall determine the time or times at which an Option may be exercised in whole or in part, and the method or methods by which, cash, property, securities (including options issued under the Plan), or any combination thereof, having a Fair Market Value on the exercise date equal to the relevant exercise price, in which, payment of the exercise price with respect thereto may be made or deemed to have been made.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iv)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">GRACE PERIOD. Except as otherwise determined by the Board or the Committee, upon termination of employment (as determined under criteria established by the Board or the Committee) for any reason during the term of an Option, the employee has 60 days after termination to exercise options vested as of the date of termination.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(v)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">INCENTIVE STOCK OPTIONS. The terms of any Incentive Stock Option granted under the Plan shall comply in all respects with the provisions of Section 422 of the Code, or any successor provision thereto, and any regulations promulgated thereunder.</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">STOCK APPRECIATION RIGHTS. The Board and the Committee are hereby authorized to grant Stock Appreciation Rights. A Stock Appreciation Right granted under the Plan shall confer on the holder thereof a right to receive, upon exercise thereof, the excess of (1) the Fair Market Value of one Share on the date of exercise or, if the Board or the Committee shall so determine in the case of any such right other than one related to any Incentive Stock Option, at any time during a specified period before or after the date of exercise over (2) the grant price of the right as specified by the Board or the Committee. Subject to the terms of the Plan, the grant price, term, methods of exercise, methods of settlement, and any other terms and conditions of any Stock Appreciation Right shall be as determined by the Board or the Committee. The Board and the Committee may impose such conditions or restrictions on the exercise of any Stock Appreciation Right as it may deem appropriate.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">RESTRICTED STOCK AND RESTRICTED STOCK UNITS.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">ISSUANCE. The Board and the Committee are hereby authorized to grant Awards of Restricted Stock and Restricted Stock Units.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(ii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">RESTRICTIONS. Shares of Restricted Stock and Restricted Stock Units shall be subject to such restrictions as the Board or the Committee may impose (including, without limitation, any limitation on the right to receive any dividend or other right or property), which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise, as the Board or the Committee may deem appropriate.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">REGISTRATION. Any Restricted Stock granted under the Plan may be evidenced in such manner as the Board or the Committee may deem appropriate, including, without limitation, book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is issued in respect of Shares of restricted Stock granted under the Plan, such certificate shall be registered in the name of the Participant and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Stock.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iv)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">FORFEITURE. Except as otherwise determined by the Board or the Committee, upon termination of employment (as determined under criteria established by the Board or the Committee) for any reason during the applicable restriction period, all Shares of Restricted Stock and all Restricted Stock Units still, in either case, subject to restriction shall be forfeited and reacquired by the Company; provided, however, that the Board or the Committee may, when it finds that a waiver would be in the best interests of the Company, waive in whole or in part any or all remaining restrictions with respect to Shares of Restricted Stock or Restricted Stock Units. Unrestricted Shares, evidenced in such manner as the Board or the Committee shall deem appropriate, shall be delivered to the Participant promptly after such Restricted Stock shall become Released Securities.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(d)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">PERFORMANCE AWARDS. The Board and the Committee are hereby authorized to grant Performance Awards. Subject to the terms of the Plan, a Performance Award granted under the Plan (i) may be denominated or payable in cash, Shares (including, without limitation, Restricted Stock), other securities, other Awards, or other property and (ii) shall confer on the holder thereof rights valued as determined by the Board or the Committee and payable to, or exercisable by, the holder of the Performance Award, in whole or in part, upon the achievement of such performance goals during such performance periods as the Board or the Committee shall establish. Subject to the terms of the Plan and any applicable Award Agreement, the performance goals to be achieved during any performance period, the length of any performance period, the amount of any Performance Award granted, and the amount of any payment or transfer to be made pursuant to any Performance Award shall be determined by the Board or the Committee. The goals established by the Board or the Committee shall be based on any one, or combination of, earnings per share, return on equity, return on assets, total shareholder return, net operating income, cash flow, revenue, economic value added, increase in Share price or cash flow return on investment, or any other measure the Board or the Committee deems appropriate. Partial achievement of the goal(s) may result in a payment or vesting corresponding to the degree of achievement.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(e)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">DIVIDEND EQUIVALENTS. The Board and the Committee are hereby authorized to grant Awards under which the holders thereof shall be entitled to receive payments equivalent to dividends or interest with respect to a number of Shares determined by the Board or the Committee, and the Board and the Committee may provide that such amounts (if any) shall be deemed to have been reinvested in additional Shares or otherwise reinvested. Subject to the terms of the Plan, such Awards may have such terms and conditions as the Board or the Committee shall determine.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(f)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">OTHER STOCK-BASED AWARDS. The Board and the Committee are hereby authorized to grant such other Awards that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares (including, without limitation, securities convertible into Shares), as are deemed by the Board or the Committee to be consistent with the purposes of the Plan, provided, however, that such grants must comply with applicable law. Subject to the terms of the Plan, the Board or the Committee shall determine the terms and conditions of such Awards.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(g)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">GENERAL.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO CASH CONSIDERATION FOR AWARDS. Awards shall be granted for no cash consideration or for such minimal cash consideration as may be required by applicable law.</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(ii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">AWARDS MAY BE GRANTED SEPARATELY OR TOGETHER. Awards may, in the discretion of the Board or the Committee, be granted either alone or in addition to, in tandem with, or in substitution for any other Award or any award granted under any other plan of the Company or any Affiliate. Awards granted in addition to or in tandem with other Awards, or in addition to or in tandem with awards granted under any other plan of the Company or any Affiliate, may be granted either at the same time or at a different time from the grant of such other Awards or awards.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">FORMS OF PAYMENT UNDER AWARDS. Subject to the terms of the Plan and of any applicable Award Agreement, payments or transfers to be made by the Company or an Affiliate upon the grant, exercise, or payment of an Award may be made in such form or forms as the Board or the Committee shall determine, including, without limitation, cash, Shares, other securities other Awards, or other property, or any combination thereof, and may be made in a single payment or transfer, in installments, or on a deferred basis, in each case in accordance with rules and procedures established by the Board or the Committee. Such rules and procedures may include, without limitation, provisions for the payment or crediting of reasonable interest on installment or deferred payments or the grant or crediting of Dividend Equivalents in respect of installment or deferred payments.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(iv)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">LIMITS ON TRANSFER OF AWARDS. No Award (other than Released Securities), and no right under any such Award, shall be assignable, alienable, saleable, or transferable by a Participant otherwise than by will or by the laws of descent and distribution; provided, however, that, if so determined by the Board or the Committee, a Participant may, in the manner established by the Board or the Committee, (a) designate a beneficiary or beneficiaries to exercise the rights of the Participant, and to receive any property distributable, with respect to any Award upon the death of the Participant or (b) transfer any Award other than an Incentive Stock Option for bona fide estate planning purposes. Each Award, and each right under any Award, shall be exercisable, during the Participant&rsquo;s lifetime, only by the Participant, a permitted transferee or, if permissible under applicable law, by the Participant&rsquo;s guardian or legal representative. No Award (other than Released Securities), and no right under any such Award, may be pledged, alienated, attached, or otherwise encumbered, and any purported pledge, alienation, attachment, or encumbrance thereof shall be void and unenforceable against the Company or any Affiliate.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(v)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">TERM OF AWARDS. The term of each Award shall be for such period as may be determined by the Board or the Committee; provided, however, that in no event shall the term of any Incentive Stock Option exceed a period of ten years from the date of its grant.</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(vi)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">PER-PERSON LIMITATION ON AWARDS. The number of Shares with respect to which Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and other Awards may be granted under the Plan to an individual Participant in any one fiscal year of the Company shall not exceed <U>2% of the outstanding</U> Shares, subject to adjustment as provided in Section 4(b). The maximum fair market value of payments to an individual Participant under Performance Awards in any one fiscal year of the Company shall not exceed $<U>1,000,000</U>.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(vii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">SHARE CERTIFICATES. All certificates for Shares or other securities delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the Board or the Committee may deem advisable under the Plan or the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange upon which such Shares or other securities are then listed, and any applicable federal or state securities laws, and the Board or the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 7. AMENDMENT AND TERMINATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except to the extent prohibited by applicable
law and unless otherwise expressly provided in an Award Agreement or in the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">AMENDMENTS TO THE PLAN. The Board may amend, alter, suspend, discontinue, or terminate the Plan, including, without limitation, any amendment, alteration, suspension, discontinuation, or termination that would impair the rights of any Participant, or any other holder or beneficiary of any Award theretofore granted, without the consent of any share owner, Participant, other holder or beneficiary of an Award, or other Person.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">AMENDMENTS TO AWARDS. The Board and the Committee may waive any conditions or rights under, amend any terms of, or amend, alter, suspend, discontinue, or terminate, any Awards theretofore granted, prospectively or retroactively, without the consent of any Participant, other holder or beneficiary of an Award.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">ADJUSTMENTS OF AWARDS UPON THE OCCURRENCE OF CERTAIN UNUSUAL OR NONRECURRING EVENTS. Except as provided in the following sentence, the Board and the Committee shall be authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4(b) hereof) affecting the Company, any Affiliate, or the financial statements of the Company or any Affiliate, or of changes in applicable laws, regulations, or accounting principles, whenever the Board or the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits to be made available under the Plan. In the case of any Award that is intended to qualify as performance-based compensation for purposes of Section 162(m) of the Code, neither the Board nor the Committee shall have authority to adjust the Award in any manner that would cause the Award to fail to meet the requirements of Section 162(m).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(d)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">CORRECTION OF DEFECTS, OMISSIONS, AND INCONSISTENCIES. The Board and the Committee may correct any defect, supply any omission, or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem desirable to carry the Plan into effect.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 8. GENERAL PROVISIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(a)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO RIGHTS TO AWARDS. No Employee, Participant or other Person shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of Employees, Directors, Consultants, other holders or beneficiaries of Awards under the Plan. The terms and conditions of Awards need not be the same with respect to each recipient.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(b)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">DELEGATION. The Board and the Committee may delegate to one or more officers or managers of the Company or any Affiliate, or a committee of such officers or managers, the authority, subject to such terms and limitations as the Board or Committee shall determine, to grant Awards to, or to cancel, modify, waive rights with respect to, alter, discontinue, suspend, or terminate Awards held by Employees, Consultants, or other holders or beneficiaries of Awards under the Plan who are not officers or directors of the Company for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and who also are not &ldquo;covered employees&rdquo; for purposes of Section 162(m) of the Code.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">WITHHOLDING. The Company or any Affiliate shall be authorized to withhold from any Award granted or any payment due or transfer made under any Award or under the Plan the amount (in cash, Shares, other securities, other Awards, or other property) of withholding taxes due in respect of an Award, its exercise, or any payment or transfer under such Award or under the Plan and to take such other action as may be necessary in the opinion of the Company or Affiliate to satisfy all obligations for the payment of such taxes.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(d)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO LIMIT ON OTHER COMPENSATION ARRANGEMENTS. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting or continuing in effect other or additional compensation arrangements, and such arrangements may be either generally applicable or applicable only in specific cases.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(e)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO RIGHT TO EMPLOYMENT. The grant of an Award shall not be construed as giving a Participant the right to remain an employee, director or consultant of the Company or any Affiliate. Further, the Company or an Affiliate may at any time terminate the service of any employee, director or consultant, free from any liability, or any claim under the Plan, unless otherwise expressly provided in the Plan or in any Award Agreement.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(f)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">GOVERNING LAW. The validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the laws of the State of Nevada and applicable federal law.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(g)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">SEVERABILITY. If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or as to any Person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Board or the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Board or the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person, or Award, and the remainder of the Plan and any such Award shall remain in full force and effect.</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(h)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO TRUST OR FUND CREATED. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and a Participant or any other Person. To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured general creditor of the Company or any Affiliate.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">NO FRACTIONAL SHARES. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award, and the Board and the Committee shall determine whether cash, other securities, or other property shall be paid or transferred in lieu of any fractional Share, or whether such fractional Shares of any rights thereto shall be canceled, terminated, or otherwise eliminated.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(j)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">HEADINGS. Headings are given to the Sections and subsections of the Plan solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 9. EFFECTIVE DATE OF THE PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the approval of the shareholders of
the Company, the Plan shall be effective <U>February 16</U>, 2016 (the &ldquo;Effective Date&rdquo;); provided, however, that to the extent
that Awards are granted under the Plan before its approval by shareholders, the Awards will be contingent on approval of the Plan by the
shareholders of the Company at an annual meeting, special meeting, or by written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECTION 10. TERM OF THE PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No Award shall be granted under the Plan more
than 10 years after the Effective Date. However, unless otherwise expressly provided in an applicable Award Agreement, any Award theretofore
granted may extend beyond such date, and the authority of the Board and the Committee to amend, alter, adjust, suspend, discontinue, or
terminate any such Award, or to waive any conditions or rights under any such Award, and the authority of the Board to amend the Plan,
shall extend beyond such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing Second Amended and Restated 2016
Equity Incentive Plan was duly adopted and approved by the Board of Directors on April 16, 2025, effective June 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ABVC BIOPHARMA, INC.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt; text-align: justify">By</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 37%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ea024658001ex23-1_abvc.htm
<DESCRIPTION>CONSENT OF SIMON & EDWARD, LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="width: 650px; height: 85px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.35pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABVC
BioPharma, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                            hereby consent to the incorporation by reference of our report in this Form S-8 of ABVC BioPharma,
                                            Inc. (the &ldquo;Company&rdquo;), to be filed on or about June 27, 2025, of our report dated
                                            April 15, 2025, with respect to our audit of the Company&rsquo;s consolidated financial statements
                                            as of December 31, 2024, and 2023 and for the years then ended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex23-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Los
Angeles, California</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">June
27, 2025</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ea024658001ex-fee_abvc.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Form S-8&nbsp;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ABVC BIOPHARMA, INC.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered Securities</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: left">Security Type</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Security<BR> Class Title</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fee<BR> Calculation<BR> Rule</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount<BR> Registered(1)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proposed<BR> Maximum<BR> Offering<BR> Price Per<BR> Unit(2)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maximum<BR> Aggregate<BR> Offering<BR> Price(2)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fee Rate</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount of<BR> Registration<BR> Fee</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: left">Equity</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">Common Stock</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">Other</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,515,989</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2.195</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">5,522,595.85</P></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.00015310</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">845.51</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="5" STYLE="text-align: left">Total Offering Amounts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">5,522,595.85</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">845.51</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="8" STYLE="text-align: center">Total Fee Offsets</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="8" STYLE="text-align: center">Net Fee Due</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">845.51</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to Rule 416 of the Securities Act of 1933, the registration statement on Form S-8 to which this exhibit relates (the &ldquo;Registration Statement&rdquo;) shall also cover any additional shares of ABVC BIOPHARMA, INC. (the &ldquo;Registrant&rdquo;) Common Stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), which become issuable under the Second Amended and Restated 2016 Equity Incentive Plan pursuant to the Registration Statement by reason of any stock dividend, stock split, recapitalization or any other similar transaction which results in an increase in the number of the Registrant&rsquo;s outstanding shares of Common Stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Estimated solely for purposes of calculating the registration fee. Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, the proposed maximum offering price per share and proposed maximum aggregate offering price are based on the reported average of the high and low prices of Common Stock as reported on the Nasdaq Capital Market on June 26, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "% 8 # 2(  A$! Q$!_\0
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M[U__ +";?^BHZW.LW**** "O%_C%_P C+9?]>7_L[5[17B_QB_Y&6R_Z\O\
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MM-;DDCRYL;A^1(J>BJ-$GW"BBBF,**** "BBB@ HHHH **** "BBB@ HHHH
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M[C8?U![CH:SM.BUC3_%^EZ3J(DN[:WBG:TU$\F2,A0$D_P"FB^O\0YZYKN,
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ML,XKAY-*FU6RUZ>R#74EIKDL[Z>7(CO8PJ91AWZ$J>F1Z5Z: %&  ![4  =
M!]* *FEZG:ZM817=H6\MARCJ5=#W5E/((]*YOQI;1W6H:1'JD<DF@/YR787.
MU9"H\MGQR #G!['!KL, $G'6B@#S%K^ZL=>T;3KK4&O[&UN?,3589&8+%M8"
M*XV\%LE<,>#C)P:].!# $$$'D$=Z:J*J[550#V IW2@#C= UC3M.D\1O=7<<
M0_M65P">6&U!D#OR#TJSXMG0Q^'7;*;M6MWVMU PW7TQFNHV+G.U<_2@@'J
M?K0 M<I>7EM:?$>![B=(E&E.I9S@9,JD#/KP:ZND*J>J@_44 <[K^HVVH>!]
M;N+9]\/V6:-7P<.0I''KSQ[U8TG6K!K/3+**X66YDA11&G)&%&2?0#WK:P,8
MP,>E 55Z*!]!0!R>F2+X<\1ZU;Z@?)MM2NA>VUT_$;$HJLA;HK IGGJ#6W!J
MT=[J2V]B1/ B%IIT.44\;5!Z$GD\=,>]:+*&4JP!!Z@C-"JJ*%4  = !B@!:
M*** "BBB@ HHHH **** "BBB@ HJMJ%R]GI\]S'$)7C7*QEMNX^F>U9DWB ?
M89+FWB!,=O-))%+E6CDC .QAVZ_U&: -RBL=]7D@^R2S?9VMIG='EC8X0A2R
M]?7!'Y4NDZQ+JI3%MY.V(F=';+12;BNPX^AH UZ*Y]O$,\,,QGM5$EJ2ERBL
M?OE@(@I/7=D'/85-J&KW6F(1<0PL[P221%&.-R+N*G/J,\^U &U17/2>)?(M
M_/E2(PK>"V:9&.QAMR2ON#\OU%;=JT[VZ-<QI'*>2BG(7VSZT 34452U*\DL
M8X)5C5HC.D<Q)QL5CC=^!(_#- %VBL.U\0BZD(\D1+$TIG+MRL:@%7'^\"II
M#X@)TA;PP+"PG,,XD)*VYYY8CM]WGMNH W:*Q+G7C;Q:H2(?,LRH1=Q^?**W
M_LV/PI;G6Y[9KG%F9Q#=)!LB/SE6C5RP!ZD9Z=\4 ;5%8S:YYEQ#%9B*87)0
M6[[C@@J[,3] AX]>*=>ZC>6=K-)MM'>%E#*KG.&( X[=3^5 &O166E]>3WUQ
M9PQP>9;*IE=B=I+9*@=^@Y/O56S\31W-S%');M#%*JJLK'*B4D@QMZ'Y>#T/
MUH WJ*HI>R'1#?%%\P0F38"<9 )Q5>'5I4-D;R.-4O(RZ/&2=I";R"#[9Y]J
M -:BLZPO+R]@M[OR8DMYUWA2QWJI&03V)Z<>]:- !116?/JJ6VLP6$J$+-"T
M@FSP&7^$_4;C_P !- &A16-9ZXUZ]CL@\M;B29'#GYDV9Q^>!^=+'KRS6VI2
M)!E[12\:;O\ 7+@[2/3)##\* -BBL=/$$4TEBL,3'[7 TH)./+(&0I]^&_[Y
M-7]/N6O--M;IU56FB60JIR!D X_6@"S1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!#=6R7=L\#LRJXP2O454N]$LKR>>=U9)I[=K:
M1T;&Y&]1TR.QHHH DETN&XLS;7+R3H75P7(!!4@C& .X_G4MO8V]I-<S0QA7
MN9/,E/JV /Y#^=%% $4FE6TWVWS0TBWFWS%)X&!@8QT_QJ*?18;I'%S//*S0
MM"K,1E%88;&!C)]3110 CZ#9R.23)L,PG:+(V,X!!.,=P>?6KEG:)8VJ6T3R
M-''PF]MQ4=AGT'2BB@">H;NUAOK.:UN$WPS(4=?4&BB@"I+HEE*\S[&5IDCC
ME*G[ZH<@'V/0^HH.BVXEN7AEE@%SCS$CV[3A=O0@]1U^@HHH 0:':+:75JK2
MK%<A58!AE0J!!CCT4>M2#2X1</-YDNYYUG(R,;E0(.W3 %%% $7]@V*SRSQ*
M\,LDJS;HVQM< C<HZ#()SV.33Y-'MYH;F.225GN&1I)<@,=I!7MCC'I110!+
M)IT;W4ES%++!-(@21HB/G SC.0>1D\U%'HEC%;2VWE;K>6-8VB8Y&!G\<\YS
MZT44 /ATQ(;&2R$TK6[1"%58@E%VX//<GKDTR/1X4:W9IIY&ME"1%R/E' /0
M=P,$]<9HHH 6+2HX(4@BN+A(8\^5&&&(_3'&>.P.:O 8 &2?<T44 +5&[TBU
MOG=KC>V_RS@-C:4)(Q^9SZCBBB@"+^PK<.72:X1C)+*"K#Y6D&&QQ^5(_A^R
M+HT>^';"("(L ,H((SQR01^IHHH 4:%9K*)(_,C83O<?*W\3*5/7MAB<>IJ[
J:6R6=G#:QEF2%%C4MUP!@9HHH FHHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "& _D# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOM/1;Z"PAGL&N':1 V) P78"Q]V_*MSPYJ%QJ>C&YN0FX2.JNH(650<!@,\
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MY+ZWMKJ159 N^!T#AC@$$KR.#S]/45=?Q180P0RO'=[Y@=L0M9#)@-@L5VY
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M%[-9:4DIBMH;<*'EQU9V()'T&/\ '8M+?4;#59WNM0:XTW[."C3!5,3 G.2
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M%Y%ND02-#-"\;[#T;# 9'TKBIFOE/BZ2UT>XN#=2PO!%<V+E) ,!F"L "1U
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MEW"D,=156>_M+4*;BYAAW_=\QPN?IGK4L4\<R!XW#J>C*<@_C19BNB6C-,+
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M6W*,'<QM+TC6_&U[-/+<L4!^>>7)4'T4?EP/6L[Q'HC^'M3%@]PDS",2$HI
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MGOG"Y]0:Q+G5]:\;:X(+:1XDEX2$2'RXU'5F['ZD>U='\13_ &5X=TC1X/\
M4GJP[A% Y^N[/UJW\*[>!='O+KC[0]QL<9Z* I'ZDU*=DY%/5J%SA_$GAB7P
MTUJ)[J*9YPQ^12-N,>OUKT/X>0-9^#VNY22)9))1GLJ@+_-2?QKA/'VJ+JOB
MB?R2&AMU6%"IX;&23_WT6'X5Z3<.FD_#<Y('EZ<$'NQ0 ?F2*<OA5PAI)V/&
MM+O;FRU&&XM@S72JRJ0,G<R%<X[G+#BN_P#!GAW5[+61K>L@I&(68F9\N#ZD
M=N,_E6+\-]-^W>)A<O\ ZNTC,F['!/W5_P ?^ UWWCV5X/!=^8\@N$C(!Z N
M 1^.2*)O7E0H)M<[//M?\0ZCXNUM=/T_S/LID\N&)21O_P!IL=L<^W-+K?@*
MZT#1WOYM0MWVLH,2J<L2<<$]>N?P-7/A8D1\17;N09!;'9GL-PR1Z=!^=:/Q
M3U5##::6'#-N,\@SRN!A?SRU&JERH7Q0<FRI\*+0OJE]?<;(H1'TZECG_P!E
M_6O60>*X/X:K'9>$I[J9@BM.[,Q[*J@?T-;MAXOT74[Q;2RO?/G;.%6)^PSD
MG&*SGK)FU*T8*YO,?E->)_$><3>+Y4_YXQ1I]#C/_LU>UM]VO!977Q%XYW D
MQW=\%R/^>9; /Y55+=L6(>B1[3X;MC9^&M.@889;=-P]"1D_J:T9I%A@DE;[
MJ*6/T I5(VC' K'\57JV/A;4YBW2!D'U8;1^K"LMV;;(\;\*H]_XRTUY/FD>
MY68YZY'S$U[XO2O&OAG9&Z\4-=8.VVA9PWHS?*/SRQ_"O9%K6KO8RH?#<Y;X
MA7XLO"5T <-.RPCWR03_ ..@UP7P_P!:TK0KJ\NM1E,<CHL<>%)R,DG_ -!6
MNB^+%P%L-/M\\O,[X^BX_P#9ZQ_"7@6T\0:.;Z\N+B$^:R)Y97#+QD\CKG(_
M"G&RA=D2;=3W2#QMXUB\20PV-A#(ELC[V>0#<[8(''8?SS7:?#O19=*\/B:=
M/+FNV\THRX*+T"D?K^-6M%\"Z+H\ZW"123W"G*R3ON*_0  ?I73;0.!4.:MR
MQ-(P=^:6XX=****S-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI<D,<\\#'YG\*Z.J_P!NMOMWV(2AKG9O,:@DJOJV.F>V>O:I<VU8I4U%WO\
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MW"R!5<+\H5AU)'J*S/A_X3O='OKF]U&U:&3:(XMSAB0>6/!/HH_.O0@<CFE
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MC-=9X/CU.+PCI<>LL[:@L $QD.6SVW>^,9]Z -NBBB@ HHHH **** "BBB@
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MS_["C_A<O_4!_P#)S_["CV%3L'UNCW/4B.*:JX'0#V%>7_\ "Y?^H#_Y.?\
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M_P"3G_V%'_"Y?^H#_P"3G_V%'L*G8/K='N>IT5Y9_P +E_Z@/_DY_P#84?\
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MN7_J _\ DY_]A1_PN7_J _\ DY_]A1["IV#ZW1[GJ=%>6?\ "Y?^H#_Y.?\
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M .PH]E5#V^'_ *1Z*FD6::J-3$;_ &L0"W#F1C\F<XP3R<]^M7J\L_X7+_U
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M*\L_X7+_ -0'_P G/_L*/^%R_P#4!_\ )S_["CV%3L'UNCW/4Z*\L_X7+_U
M?_)S_P"PH_X7+_U ?_)S_P"PH]A4[!];H]SU.BO+/^%R_P#4!_\ )S_["C_A
M<O\ U ?_ "<_^PH]A4[!];H]SU.BO+/^%R_]0'_R<_\ L*/^%R_]0'_R<_\
ML*/85.P?6Z/<]3HKRS_A<O\ U ?_ "<_^PH_X7+_ -0'_P G/_L*/85.P?6Z
M/<]3HKS;3/BQ_:6K6=C_ &)Y?VF=(=_VK.W<P&<;.>M>DU$H2A\1M3JPJ*\6
M<7X_\(:AXJ_L[[#-;1_9O,W^>S#.[;C&%/\ =-<7_P *BU__ )_-,_[^R?\
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M .?S3/\ O[)_\1111]8F'U*E_3#_ (5%K_\ S^:9_P!_9/\ XBC_ (5%K_\
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M //YIG_?V3_XBC_A46O_ //YIG_?V3_XBBBCZQ,/J5+^F'_"HM?_ .?S3/\
MO[)_\11_PJ+7_P#G\TS_ +^R?_$444?6)A]2I?TP_P"%1:__ ,_FF?\ ?V3_
M .(H_P"%1:__ ,_FF?\ ?V3_ .(HHH^L3#ZE2_IA_P *BU__ )_-,_[^R?\
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M +^R?_$444?6)A]2I?TP_P"%1:__ ,_FF?\ ?V3_ .(H_P"%1:__ ,_FF?\
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M?\*BU_\ Y_-,_P"_LG_Q%%%'UB8?4J7],/\ A46O_P#/YIG_ ']D_P#B*/\
MA46O_P#/YIG_ ']D_P#B***/K$P^I4OZ8?\ "HM?_P"?S3/^_LG_ ,11_P *
MBU__ )_-,_[^R?\ Q%%%'UB8?4J7],/^%1:__P _FF?]_9/_ (BC_A46O_\
M/YIG_?V3_P"(HHH^L3#ZE2_IA_PJ+7_^?S3/^_LG_P 11_PJ+7_^?S3/^_LG
M_P 1111]8F'U*E_3#_A46O\ _/YIG_?V3_XBC_A46O\ _/YIG_?V3_XBBBCZ
MQ,/J5+^F'_"HM?\ ^?S3/^_LG_Q%'_"HM?\ ^?S3/^_LG_Q%%%'UB8?4J7],
M/^%1:_\ \_FF?]_9/_B*/^%1:_\ \_FF?]_9/_B***/K$P^I4OZ8?\*BU_\
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*5F]*C&DFHG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H .@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBN-\1?
M%'PEX7F\C4-41[@Y_<VP,K#''.W@?B: .RHKR[2/COX7U?7+72XK;4(WNI%B
MBD>(;2[-M .#D=1S7J- !1110 4444 %%%(S!1D]!UH 6BN);XK^$QJL5B+V
M5EEF^SI=+ YMS)_=$F,$\]J[;MS0 45S'B'X@^%_"LIAU?5H8;@*&\A 7DQ_
MNJ#C\:Q=&^,_A#7=9MM*LI[O[3<R>7$9+<A68]!GM0!Z#10:K66H6>HI(UG=
M0SB)S')Y3AMC#JI]#0!9HHHH **** "BBJMKJ-G?3W,-K<Q3/:R>5.J-DQO@
M':?0X(H M4444 %%<==?$?1H?'%EX2MA+>ZC.[)-Y RMO@$_,?7CD#I78,ZH
MI9F"J!DDG  H 6BO/%^,OA5M:U&R%PWV73X#++??\LF(8+L0=6.3QCK6#=?M
M%^&(IW2WT[4KA%Z2!54-^!.10![#17!>"OBOH_C/4GTM;6ZT_4E5G%O<K]Y1
MCD$=^>E% '7ZS]M_L:]&FJC7Y@<6XD;:OF8.W)[<XKYGT71!X1GEN/&_PZU;
M4Y'9GDNQ+YD:C/)V ;2>IR6KV#XK77CJ"/2AX,MYI!YCM=- %+<8VJ0?X3D_
ME7F^JZ_\:O$$<MHFC7M@JL0_V2V,)(/8.QY'N#^- '6^$)/A5;6FH^,['RXG
MMY?,E-VN'LRWW42,<#N!MR3Z\5FV'Q#GO]<U#QU>ZS<67A.R<VUGIFSY[R39
MP,=,Y^;.3CIQUKF=<^%&N>'OAK-<SHU[J4M_%<75O;9?;$%<88C[Q!;.1Z_C
M3O%_ASQ?XQTWP[):>&6TO3$;[+::9&KDVX."9I.!M4G/)'0<^X!W<GQ_\//?
M:1;6EK(Z7;)]LFG?RELP<9SP=Q'.<8''6MO2?C%X9U6#6KPO+;6&ELH^TS+@
M3[B0-BCG)(X'7D=*\3O?@IX@2?7I8;2Y%GIRG[+N4-)>L./D4=CRWTP.35E/
M 7CF7X7+:/H:165O>?:S;",F]N"?E+ <[0!CC )Z\T >N>$/C)H_C'Q/_8MG
M8W,!9'>*6=E&_;VP"><9/X4^3XV^#(X]0<7=PRV9"@B''GL>,1YY;H>3@"O+
M8?ASXPU&]U7Q1I>E1Z/"8)HK33[@$7 B\K8 B@<,5X!)'.361=_"GQ3%X8TE
MAH%S<WURY)5'"_9H^R.O9FSDL>@ '6@#Z.\&^*8O&'AJVUJ&TFM8YBP\N7J-
MK$<'N/<5YO\ &;XAVZZ5J'A+1_M,^I%0;R2W!VVT8(+!B/4<'L,\GM7H7@ZQ
MURPTL1ZTUG'@*MM8V:'99Q*,!-YY<XQDGOTKPS^ROB'X:UKQ)HNF>&S<R:U)
M(9+\PF0-"Q;A7)V@'=DYYS0!-\/8]%B7PIJ&OZNVHWK3_9M(T>U'RVV7P9)1
MQ@Y).>_!Y[?1\P<PLL9PY4A3G&#CBOGOX8?#+Q%X8^)4<NKZ3"UM;0&3[7O+
M(K,I \LC&7R2#D<#)]#7H7QJUO6-#\!/+HZR(TTRPSW,?WH(R"21CID@+GMG
MWH \=LX-(\"ZQ>?\)KHD7B#599R%\F_CF"KUR8_O;L_WL<&O4O!%MX3U22]\
M6OX2DT3[,R-%<7^U$0*OWHQP% &,G')/6N'\-?$KP3X1TV*#POX6U&^U5P!+
M-.%$DC>[#<>N<  5KZQ8_$[QUX*U6:^L?LR7$\!M])&V-FA4DMUYR24/S$9P
M>.E &KXC^,D6JF70?"%A?76HWQ^S65Z4V0LQX9U)Y.T'KCWZ#F6R\0:7\++?
M3/!6FV\FM^(+F8/=K$X3YWP6=V.<<= >PR2!S6+8>#O&VB>/=,U&TT6PGQIY
MC@5I"EGIC,3E5P2S8!Y[L78YJMJOPZ\=MJWB22..UN+B]5Y?[:R%EECV8^SQ
MIG]WN^Z3Z<9QU /0Y_B]X6ALKR\66XF@@NULHFB0-]JE."1$,_,%R,G@<CKD
M9M^*_B7H?A1Q:OYM_JK_ '-/LAYDO3)+#^$8YYY]J\U\-?"SQ%JEEH$VHBVT
M2'1SNM[2:#[0TTA?<\L@#* 20N 2>%%9UW\/_&D.DZ\T6E2#5&FD,NIQSA[G
M4=[C"H,CRX]I);').!TR  >@P?&33_\ A7+>+;W3);;=</:P6@F#F:0#( ?
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@H **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
